Women Building Bio: the XX factor is a day long conference to recognize and learn from leading women in the bioscience industry as pioneers paving the path to success. These women have faced their own unique challenges and carved out lasting legacies.

This day will catalyze the formation of a diverse network. It is a convergence of academia and industry, men and women, researchers and innovators, professionals and decision-makers gathering together to build relationships. This day long conference provides extraordinary opportunities to exchange new ideas, highlight areas of bioscience and research opportunities, and find partners for future collaboration.

GlaxoSmithKline is scrapping more than 30 drug development programs. The major cull of pipeline prospects will see GSK focus 80% of its R&D budget on the top candidates in four therapeutic areas and potentially exit the rare disease space.

The Inova Personalized Health Accelerator (IPHA) announced today that health and biosciences industry veteran Michael Thomas has been appointed Director of the Accelerator. Prior to joining Inova, Michael was founder and CEO of Appian Partners, an Annapolis life sciences consulting practice. His med-tech experience has spanned several early stage, growth stage, and turn-around ventures as CEO of Appian Partners, ReGear Life Sciences, NuSomnea, Tanzen Medical, Mommy's Medicine Cabinet, Appian Medical, iSonea, and NovaSom. He also served on the board of directors for AdvaMed and Circadiance. He started his career in the pharmaceutical industry with Merck & Company and GlaxoSmithKline. Michael earned a BS in Microbiology from Cornell University.

In the run up to the inaugural Techweek Washington D.C., presented this year by AARP and held Oct. 2-6, Techweek today announced the Techweek100, honoring leading technology-focused firms in the D.C. area, as selected by an Executive Advisory Board comprised of 10 D.C.-based tech leaders.

A number of local movers and shakers with ties to Johns Hopkins have landed on the "40 Under 40" list published by the Baltimore Business Journal.

The journal's annual list takes note of "innovators, professionals, and entrepreneurs in Greater Baltimore who have already made great strides before the age of 40," including developers, CEOs, educators, and nonprofit founders. A Nov. 16 ceremony will celebrate this year's b

The Inova Personalized Health Accelerator (IPHA) announced today that health and biosciences industry veteran Michael Thomas has been appointed Director of the Accelerator. Prior to joining Inova, Michael was founder and CEO of Appian Partners, an Annapolis life sciences consulting practice. His med-tech experience has spanned several early stage, growth stage, and turn-around ventures as CEO of Appian Partners, ReGear Life Sciences, NuSomnea, Tanzen Medical, Mommy's Medicine Cabinet, Appian Medical, iSonea, and NovaSom. He also served on the board of directors for AdvaMed and Circadiance. He started his career in the pharmaceutical industry with Merck & Company and GlaxoSmithKline. Michael earned a BS in Microbiology from Cornell University.

Dimension Therapeutics has agreed to be acquired by RegenxBio, the gene therapy developer that originally helped form the company four years ago.

RegenxBio (NASDAQ: RGNX), based in Rockville, MD, will pay $3.41 per share in the all-stock deal valued at approximately $86 million. By comparison, Cambridge, MA-based Dimension (NASDAQ: DMTX) went public at $13 per share in 2015. Dimension’s closing stock price on Thursday was $1.20.

The academic biomedical research community is a hub of employment, economic productivity, and scientific progress. Academic research institutions are drivers of economic development in their local and state economies and, by extension, the national economy. Beyond the economic input that the academic biomedical research community both receives and provides, it generates knowledge that in turn affects society in myriad ways.

The 2018 FLC Awards is now open for nominations.  One of the most coveted honors in the technology transfer field, the FLC awards have been presented to over 200 federal laboratories since their inception in 1984. Many of our winning technology transfer efforts have gone on to become products and devices that are indispensable in our daily lives, including:

Inova Genomics Laboratory is thrilled to offer you our exclusive MediMap® PGx (pharmacogenomics) panel – as well as tests for up to two family members, if applicable at your event.

What is MediMap?

MediMap is a one-time genetic test that may indicate how a person will respond to some prescription medications. The test helps guide healthcare providers to better medication choices and doses for their patients. MediMap testing provides information to more effectively manage illnesses and improve patients' health. To learn more, please visit www.inova.org/MediMap.   What's involved?

All that's needed is a painless cheek swab, which we will conduct after you have registered by filling out the form below.

The PMatX Yavne incubator will serve Israeli startups and focus on next-generation electronics and advanced materials.

German pharmaceutical, life sciences and chemicals giant Merck Group today announced the founding of a technological innovation laboratory that will function as an incubator for startups in Israel. The incubator, to be called PMatX, will focus on next-generation electronics. The program will be supported by other partners, including printing solutions manufacturer HP and the Battery Ventures fund.

New York City’s existing 1.7 million s/f of life science and research space is currently fully occupied, pushing companies to establish outposts in Westchester County and New Jersey.

According to a report from brokerage firm Transwestern, New York City is facing space constraints as it hosts the highest concentration of academic institutions and the largest life science workforce in the country.

It’s a common trope that government has a lot to learn from Silicon Valley when it comes to technology. But in cybersecurity, Washington is leading the way in many respects.

When federal leaders and lawmakers praise industry’s tech savvy, they're usually talking about innovation, flexibility and speed to market. IT companies aren't burdened by a labyrinthine acquisition process. They can shift quickly when customers want something different, abandon failing efforts and push products out at the lowest cost.

DATE AND TIME: Tue, September 19, 20177:30 AM – 10:00 AM EDT

LOCATION: American Visionary Art Museum800 Key Highway JRVC 3rd Floor Baltimore, MD 21230

Already dubbed a ‘tech hub’, the Baltimore-Washington region has built a solid foundation in cyber activities as they pertain to government agencies and defense contracting. Now a transformation is underway to build up the commercial side of cyber. And that’s precisely what this panel will reinforce.

Cambridge headquartered AstraZeneca and its global biologics R & D arm MedImmune, plan to develop new therapies for respiratory disease through a five-year collaboration with Munich-based Ethris GmbH.

The Cambridge UK duo will pay Ethris €25 million upfront, plus research funding; Ethris is also eligible for future R & D milestones, including sales-related royalties on commercialisation.

Gaithersburg-based immunotherapy company Altimmune Inc. announced Tuesday it plans to expand into a new headquarters, but it's not going far.

Altimmune (NASDAQ: ALT) officials said they plan to relocate existing employees — as well as new employees acquired as a result of its acquisition of Annapolis biodefense company PharmAthene Inc. — to a 14,000-square-foot space at 910 Clopper Road. The company is currently based at 19 Firstfield Road, less than a mile away.

Intralytix, Inc. announced that it received $17.5 million in new equity funding from Lesaffre, a French family group. This investment marks the beginning of a close collaboration between both companies to develop and commercialize bacteriophage-based products, for various benefits in human health and in other areas of mutual interest.

As a global key player in yeasts and fermentation, Lesaffre designs, manufactures and markets innovative solutions for Baking, Food taste & pleasure, Health care and Biotechnology. This new investment is perfectly in line with Lesaffre’s ongoing expansion strategy in nutrition and health. In 2015, Lesaffre had already announced the investment in Gnosis, an Italian company specialized in ingredients for the pharmaceutical, nutraceutical, cosmetic and veterinary industries.

Deadline Extended to August 24, 2017! Submit your proposal today

There's still time to submit your proposal for the "Make Your Medical Device Pitch for Kids!" competition. Deadline extended to Thursday, August 24, 2017 at midnight PDT.

Up to six prizes totaling $250,000 will be awarded to the winning presentations at the nation's leading pediatric innovation symposium on Sunday, September 24, 2017. Are you registered for the Symposium?

Join us for the 5th Annual Pediatric Device Innovation Symposium in San Jose, CA - one day before The MedTech Conference powered by AdvaMed.

It's a results-driven day that brings together medical device innovators, investors, researchers, clinicians, and policy makers to stimulate pediatric device innovation and bring solutions to market faster for the benefit of children everywhere.

Innovation is a principal driver of U.S. economic growth. In 2016, the U.S. spent an estimated $514 billion on research and development — more than any other country in the world — helping the nation rank No. 4 on the Global Innovation Index. According to the results of the ranking, knowledge and technology outputs are America’s particular strengths.

But certain states are due more credit than others for America’s dominance in the tech era. These states continue to foster innovation through investments in education, research and business creation, especially in highly specialized industries.

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, today announced, following a four-day bench trial, that the United States District Court for the District of New Jersey ruled that TWi Pharmaceuticals, Inc. and its subsidiary infringed U.S. Patent Nos. 7,722,898, 7,910,131, and 8,821,930 by submitting to the FDA an Abbreviated New Drug Application (ANDA) seeking permission to market a generic version of Oxtellar XR® before the expiration of Supernus' patents.  The District Court ruling also confirmed the validity of U.S. Patent Nos. 7,722,898, 7,910,131, and 8,821,930.

The National Institute of Standards and Technology on Wednesday published new guidance on how to strengthen passwords. Why now? Research shows that the de facto standard practice of requiring users to include a mix of uppercase and lowercase letters, numbers and at least one symbol, is more trouble than it’s worth.

“Analyses of breached password databases reveal that the benefit of such rules is not nearly as significant as initially thought,” NIST explained. “The impact on usability and memorability is severe.”

Maryland gained 800 jobs in July and unemployment fell for the third consecutive month.

The private sector added 11,500 positions while government positions decreased by 10,700, according to preliminary data released Friday by the U.S. Department of Labor. Maryland's unemployment rate dropped to 4 percent in July from 4.1 percent.

Senseonics Holdings, Inc. (NYSE MKT: SENS), a medical technology company focused on the development and commercialization of Eversense®, a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced the pricing of its previously announced underwritten public offering. Senseonics is offering 11,637,500 shares of its common stock, par value $0.001 per share, at a price to the public of $2.15 per share. In connection with the offering, Senseonics has also granted the underwriter a 30-day option to purchase up to an additional 1,745,625 shares of common stock offered in the public offering to cover over-allotments, if any. Senseonics intends to use the net proceeds from the offering primarily to begin commercialization of Eversense in the United States, if approved, to fund continued research and development of future configurations of Eversense, and for working capital and general corporate purposes. The offering is expected to close on August 23, 2017, subject to the satisfaction or waiver of customary closing conditions.

Venture capital spending continues to lag behind the record activity of recent years, but startups needn't worry; industry analysts say there's still billions in dealmaking still to be done.

Nationally, VC firms invested roughly $38 billion in startups and other early-stage companies during the first two quarters this year, down 10 percent from the $42 billion recorded during the same span in 2016 and off about $2 billion from 2015, according to data collected by Pitchbook and the National Venture Capital Association.

Imagine a workplace with no desk or office of your own, even if you are the company’s CEO.

Instead, you work in a neighborhood-style space, fitted for a time when workers — especially millennials — do not need to sit at the same cubicle for 40 hours a week.

The Maryland Technology Enterprise Institute (Mtech) at the University of Maryland, College Park seeks an organized, energetic person to assist with operational functions and related activities for the Entrepreneurship and Innovation Program in the Honors College.

This nationally award-winning program helps to develop the entrepreneurial mindsets, skill sets, and resources for first and second-year students. The position-holder would provide coordination and support for: 1.) program operations and administration; 2.) courses and curriculum; 3.) student activities and engagement; 4.) marketing and recruiting; and 5.) development and grants.

This is an exciting opportunity for a self-starting, highly motivated, tech-savvy individual with experience in or desire to engage in an entrepreneurial and/or higher education environment. The ideal candidate will possess a Bachelor's degree along with excellent skills in verbal, written and interpersonal communication, teamwork, multi-tasking, problem-solving, event management, and customer service.

This is a 6-month, hourly, contractual position, up to 40 hours per week, that would begin immediately. To apply, please send a resume and cover letter to This email address is being protected from spambots. You need JavaScript enabled to view it.. For best consideration, please apply by August 28, 2017.

The Cybersecurity Association of Maryland has a pair of new board members.

Silent Circle CEO Gregg Smith and EZShield VP of Technology Darrell Laffoon were elected to the board of the organization, according to a statement. Elected to a second term was Karen Austin, publisher of United States Security Magazine.

Johns Hopkins’ accelerator for impact-focused entrepreneurs opened up applications for its next cohort.

The JHU Social Innovation Lab will accept up to 10 companies for the next cohort, which begins in the fall. The program is open to entrepreneurs who are Greater Baltimore residents, as well as the Johns Hopkins community.

Montgomery County, particularly Gaithersburg, has become a central hub for vaccine research and development, and to a lesser extent for vaccine manufacturing.

The County is a key vaccine development center “not only for the country, but the world,” said Brad Fackler, senior director for life sciences at the c.

Netherlands-based biotechnology firm MIMETAS has partnered with Roche to develop a new organ-on-a-chip system to support intestinal permeability assessment.

The new system is designed to enable evaluation in perfused three-dimensional (3D) gut tubules in high throughput under exposure to pharmacological compounds. As part of their research, the firms are reported to have grown more than 350 gut tubules under flow to form leak-tight structures.

Altimmune, a drug company based in Gaithersburg, has agreements with investors to raise about $14.7 million, excluding fees and expenses, in a second round of financing. The company plans to sell 15,565 shares of convertible preferred stock and warrants to new and existing investors in a round that the company expects to close around Aug. 21.

September 18, 2017 | 12:00 PM - 2:00 PM - Maryland Department of Commerce World Trade Center Baltimore 401 East Pratt Street, 17th floor  

The Maryland Department of Commerce invites you to learn about the new Maryland Defense Diversification Assistance Program that is designed to assist Maryland companies with dependence on US Department of Defense contracts to expand into international markets. The presentation will highlight Australia (particularly the State of Victoria) as a destination for exporting and partnerships.

Muhammad Najee-Ullah has long been interested in technology, and he recognized the potential for art, tech and design to engage youth in Baltimore.

With Pop-Up Robotic Gaming Grounds (PURGG), Najee-Ullah introduces youth to STEAM. At after-school programs and events, PURGG lets students compete with teams of robots to gather items on a field. It’s also about learning what goes into designing and building the robots through educational “Design/Build/Compete” workshops that introduce coding, 3D printing, game design and plenty of other concepts.

9 November 2017 - Munich

Future X Healthcare offers a unique platform to connect key innovation drivers in healthcare for an open and inspiring exchange of ideas, insights and solutions. The one-day event fosters new networks between the worlds of science, industry, VCs, accelerators, start-ups and politics.  

The mission for 2017: to shape the future of healthcare by making big data meaningful – from science to patient care. The increasing availability of healthcare data – from genomic profiling, advanced imaging, digital biomarkers to electronic health records and mobile health – creates the foundation and framework for a more targeted, personalized healthcare. Together, we can change the way we do research, prevent and diagnose diseases, and treat patients.  

Experience a day full of inspiration at Alte Bayerische Staatsbank in Munich with top speakers, start-up pitches, a networking innovation fair and two brand-new awards.